NeoGenomics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NeoGenomics generated cash of -$1,953,000, which is more than the previous year. Cash used in financing activities reached the amount of $4,554,000 last year. Net change in cash is therefore $79,308,000.
Cash Flow
| 2014 | 9.45M | -9.60M | 29.00M |
|---|---|---|---|
| 2015 | 6.39M | -75.15M | 58.49M |
| 2016 | 21.47M | -6.50M | -25.87M |
| 2017 | 18.03M | -13.69M | -4.09M |
| 2018 | 44.78M | -139.68M | 91.95M |
| 2019 | 23.36M | -19.63M | 159.46M |
| 2020 | 1.46M | -159.44M | 235.59M |
| 2021 | -26.72M | -632.36M | 725.28M |
| 2022 | -65.99M | 517K | 11.82M |
| 2023 | -1.95M | 76.70M | 4.55M |
NEO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 263.18M | 316.82M | 250.63M | 173.01M | 9.81M | 12.82M | 12.52M | 23.42M | 33.68M | 4.83M |
Operating activities | ||||||||||
Net income | -87.96M | -144.25M | -8.34M | 4.17M | 8.00M | 2.64M | -846K | -5.72M | -2.53M | 1.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 72.58M | 69.43M | 53.35M | 35.72M | 30.27M | 21.73M | 22.59M | 23.20M | 7.14M | 5.64M |
Stock-based compensation expense | 24.63M | 24.67M | 22.45M | 10.21M | 10M | 0 | 6.44M | 5.43M | 3.47M | 692K |
| Deferred income tax benefit | 24.63M | 24.67M | 22.45M | 10.21M | 10M | 0 | 6.44M | 5.43M | 3.47M | 692K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -11.51M | -7.58M | -4.69M | -12.60M | -17.30M | 209K | -24.24M | -18.42M | -3.21M | -2.77M |
Inventories | -454K | -1.1M | 1.63M | -15.19M | -5.75M | 734K | -1.42M | -1.14M | -896K | -229K |
Accounts payable | -4.54M | 2.79M | 5.15M | -3.97M | -9.00M | 12.92M | -4.54M | -2.10M | 5.90M | 2.46M |
Cash generated by operating activities | -1.95M | -65.99M | -26.72M | 1.46M | 23.36M | 44.78M | 18.03M | 21.47M | 6.39M | 9.45M |
Investing activities | ||||||||||
Purchases Of Investments | -6.75M | -97.60M | -196.79M | -73.10M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -28.75M | -30.89M | -64.14M | -29.09M | -20.02M | -14.31M | -13.69M | -7.53M | -2.21M | -3.77M |
Acquisitions Net | 0 | 0 | -419.40M | -62.6M | 399K | -125.37M | 0 | 1.03M | -72.94M | -5.83M |
Cash generated by investing activities | 76.70M | 517K | -632.36M | -159.44M | -19.63M | -139.68M | -13.69M | -6.50M | -75.15M | -9.60M |
Financing activities | ||||||||||
Common Stock Issued | 4.62M | 12.58M | 423.21M | 147.60M | 171.97M | 144.09M | 2.58M | 4.03M | 1.08M | 34.25M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -50.09M | 0 | -55M | 0 | 0 |
Repayments of term debt | -70K | 0 | -3.04M | -103.15M | -12.51M | -11.06M | -6.68M | -60.29M | 60.90M | -7.86M |
Cash used in financing activities | 4.55M | 11.82M | 725.28M | 235.59M | 159.46M | 91.95M | -4.09M | -25.87M | 58.49M | 29.00M |
Net Change In Cash | 79.30M | -53.64M | 66.19M | 77.61M | 163.20M | -3.01M | 296K | -10.89M | -10.26M | 28.85M |
Cash at end of period | 342.48M | 263.18M | 316.82M | 250.63M | 173.01M | 9.81M | 12.82M | 12.52M | 23.42M | 33.68M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |